SHERIDAN, WYOMING - December 3, 2025 - AGC Biologics has signed a new manufacturing agreement with AAVantgarde Bio to produce dual-vector AAV gene therapies for Stargardt disease and retinitis pigmentosa, positioning its BravoAAV™ platform at the center of next-generation treatments for inherited retinal disorders with no approved therapies.

Dual-vector AAV platform targets previously "untreatable" retinal genes

Under the deal, AGC Biologics will provide GMP manufacturing for AAVantgarde's two clinical-stage candidates: AAVB-039 for Stargardt disease, the most common inherited form of macular degeneration in children and young adults, and AAVB-081 for retinitis pigmentosa caused by Usher syndrome type 1B. Both programs are in Phase 1/2 trials, with AAVB-039 being tested in the U.S., UK and Europe, and AAVB-081 representing the first-ever dual AAV gene therapy in an ocular indication.

SHERIDAN, WYOMING - December 3, 2025 - AGC Biologics has signed a strategic development and manufacturing agreement with Repair Biotechnologies to advance a novel mRNA therapeutic aimed at rapidly stabilizing and shrinking atherosclerotic plaques, addressing what both partners describe as the leading single cause of human mortality worldwide.

Targeting plaque biology in a high-burden cardiovascular market

The collaboration focuses on an mRNA-based therapy designed to stabilize and reduce atherosclerotic plaques in major blood vessels, directly tackling the root pathology behind heart attacks and strokes. Rupture of unstable plaque and subsequent thrombotic events account for an estimated 27% of all human deaths, underscoring the strategic importance of any technology capable of reversing or halting plaque progression.

SHERIDAN, WYOMING - December 3, 2025 - AGC Biologics is partnering with public benefit company Rarity PBC to bring a potentially life-saving gene therapy for Adenosine Deaminase Severe Combined Immunodeficiency (ADA-SCID) through commercial manufacturing and toward FDA approval, underscoring how CDMO collaborations are becoming central to translating academic breakthroughs into scalable rare disease treatments.

From transformational trials to a U.S. commercial pathway

Under the new agreement, AGC Biologics will provide end-to-end development and GMP manufacturing for Rarity's ex vivo autologous gene therapy RDP-101. If approved, RDP-101 would become the first gene therapy commercially available in the United States to reverse ADA-SCID, a rare inherited immunodeficiency that leaves infants dangerously exposed to severe, recurrent infections.

SHERIDAN, WYOMING - December 3, 2025 - Solar Solutions Düsseldorf 2025 is set to reinforce North Rhine-Westphalia's role as a high-potential market for renewables, bringing more than 250 exhibitors and a tightly focused B2B audience together under one roof to drive solar, storage, EV charging and green HVAC deployment in Germany's most populous state.

A growing regional platform for solar and smart energy

On Wednesday 3 December and Thursday 4 December 2025, Messe Düsseldorf will again host Solar Solutions Düsseldorf as the central platform for renewable energy in North Rhine-Westphalia. The exhibition continues to scale, with more than 250 exhibitors now spanning 27,050 square meters across two halls, reflecting both supply-side momentum and the demand from installers, planners, energy consultants and other sustainability professionals.

SHERIDAN, WYOMING - December 2, 2025 - Ricoh has introduced its new IM Cxx01CE A3 color multifunction series, positioning the IM C2501CE, IM C3501CE and IM C5501CE as a new sustainability benchmark for office print fleets by combining high reuse rates, lower CO₂ footprint and upgraded security with cloud-ready workflows.

Circular-economy design with high reuse and lower CO₂ footprint

Developed explicitly with circular-economy principles in mind, the new IM Cxx01CE models are manufactured using over 86% reused components and deliver a CO₂ footprint reduced by around 50% compared to comparable multifunction systems. By building on existing hardware resources and refreshing them with the latest security and performance elements, Ricoh enables customers to pursue sustainability targets while maintaining familiar functionality and reliability.

SHERIDAN, WYOMING - December 2, 2025 - Ricoh and Neat have signed a global partnership agreement to deliver integrated, high-end audiovisual solutions for modern workplaces worldwide, combining Neat's AI-driven video devices with Ricoh's AV Managed Services to enhance hybrid collaboration and workplace experience.

Master-level alliance to scale premium meeting experiences

Under the agreement, Neat, a global leader in professional AV and innovative video technology, and Ricoh, a global leading AV integrator, will collaborate at the highest tier of Neat's Global Partner Program-the Mastery level. The partnership is designed to expand Ricoh's portfolio of high-end meeting room solutions and make Neat-powered spaces more accessible across enterprises of all sizes.

SHERIDAN, WYOMING - December 2, 2025 - Heidelberger Druckmaschinen AG (HEIDELBERG) is restructuring its largest site in Wiesloch-Walldorf, appointing long-time manager Orhan Bekyigit as plant director alongside his existing role as site head, in a move designed to sharpen competitiveness, streamline operations and support growth in international markets.

Strategic realignment at Heidelberg's largest production hub

The Wiesloch-Walldorf campus, with around 3,800 employees, is HEIDELBERG's biggest location worldwide and a central pillar of its global manufacturing and technology network. The new setup brings plant management and central site functions under one leadership, with Bekyigit now responsible for both operational execution and cross-site coordination.

SHERIDAN, WYOMING - December 2, 2025 - More than 3,000 print service providers worldwide are now using the cloud-based HEIDELBERG Customer Portal as a digital control center for their end-to-end production, underscoring how system integration and workflow automation are becoming decisive competitive factors in the global print and packaging industry.

Cloud platform becomes a digital command center for print plants

Three years after launch, Heidelberger Druckmaschinen AG's (HEIDELBERG) customer portal is evolving into a central hub for managing production, service and commercial processes. Over 7,000 individual users are actively leveraging the platform to digitalize and automate their operations, with a clear focus on improving efficiency, transparency and sustainability.

SHERIDAN, WYOMING - December 2, 2025 - Swiss communications provider rubmedia has commissioned a compact, highly automated Heidelberg digital print line at its new site in Köniz near Bern, combining a Jetfire 50 inkjet system, a Versafire LV toner press and integrated workflow software to industrialize personalized short-run production.

Digital production line anchors new Köniz facility

With around 35 employees, rubmedia positions itself as a media house focused on creative communication solutions for service providers, industry, associations and political customers. As part of an internal transformation project linked to its relocation, the company rethought its production strategy and installed a tightly integrated digital line designed for efficiency, quality and automation.

SHERIDAN, WYOMING - December 2, 2025 - Heidelberger Druckmaschinen AG (HEIDELBERG) is reporting a significantly more profitable first half of its 2025/2026 financial year, with revenue growth, a doubling of EBITDA and improving cash flow underscoring the impact of its restructuring program and strategic focus on packaging, label and digital print.

Stronger top line and sharply improved margins

In the six months from April 1 to September 30, 2025, HEIDELBERG grew revenue to €985 million, around 8% above the prior-year period's €915 million. Europe and Asia were the main regional growth engines, while the second quarter contributed €519 million, up from €466 million in the first quarter despite negative currency effects of roughly €12 million versus the prior-year quarter.